Pitolisant and Fostemsavir: Interaction Details
- Pitolisant
- Wakix
- Fostemsavir
- Rukobia
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Pitolisant and Fostemsavir interaction:
What Happens When You Take Pitolisant With Fostemsavir
What can happen when they are taken together (rated Major)
Increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Fostemsavir should be coadministered with care alongside any drug that carries a known risk of torsade de pointes, since the combination may raise the likelihood of torsade de pointes.1
The Pitolisant and Fostemsavir Interaction, Explained
Both pitolisant (Wakix), used for sleepiness from narcolepsy, and fostemsavir (Rukobia), an HIV medicine, can slightly lengthen the heart's electrical recharge time (the ). Taken together, these effects may add up and, in rare cases, raise the chance of a serious irregular heart rhythm called .
This is a theoretical concern, not something proven in people taking this pair. Keep taking both as prescribed. Tell your pharmacist or doctor about any heart rhythm problems, fainting, or other medicines you take, and let them know right away if you have a racing or fluttering heartbeat or feel faint. Your care team can manage this by monitoring you.
Mechanism: () between pitolisant and fostemsavir (its active moiety, temsavir, has been associated with QTc prolongation at supratherapeutic exposures). Neither drug is being treated as altering the other's exposure here. This is not a -driven interaction.
- Effect: Increased risk of .
- Evidence: Theoretical; onset unspecified.
- Management: Use caution with . Consider baseline and monitoring in patients with additional risk factors (congenital long QT, , structural heart disease, , , other QT-prolonging drugs). Correct electrolyte abnormalities. Counsel patients to report syncope or palpitations.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Pitolisant and Fostemsavir Interact
The likely mechanism
How to Manage the Pitolisant and Fostemsavir Interaction
Your care team can usually continue both medicines while taking some extra care.
- Keep taking both as prescribed, and do not stop either one on your own.
- Your team may monitor you more closely, and your doses may need to be adjusted and individualized by your care team.
- Tell them about any history of heart rhythm problems, a family history of long QT, or other medicines you take that affect heart rhythm.
- Contact your pharmacist or prescriber promptly if you notice fainting, dizziness, or a racing or irregular heartbeat.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Pitolisant or Fostemsavir need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Pitolisant and Fostemsavir: Common Questions
How serious is the Pitolisant and Fostemsavir interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Pitolisant and Fostemsavir interaction managed?
Your care team can usually continue both medicines while taking some extra care. Keep taking both as prescribed, and do not stop either one on your own. Your team may monitor you more closely, and your doses may need to be adjusted and individualized by your care team. Tell them about any history of heart rhythm problems, a family history of long QT, or other medicines you take that affect heart r… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Pitolisant and Fostemsavir Interaction
Ask in your own words about taking Pitolisant and Fostemsavir together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: RUKOBIA oral extended-release tablets, fostemsavir oral extended-release tablets. ViiV Healthcare (per FDA), Durham, NC, 2024. DailyMed
Other Serious Interactions of Pitolisant and Fostemsavir
Also serious with Pitolisant
- Ketoconazole TopicalContraindicated
- DronedaroneContraindicated
- FluconazoleContraindicated
- Fluconazole InjectionContraindicated
Also serious with Fostemsavir
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.